Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01197495 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation

A NA study, sponsored by Allergan.

Completed
Registry status
NA
Development phase
213
Enrollment target

NCT01197495 is a NA study that has completed, run by Allergan. The registered enrollment target is 213 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01197495, a NA study, has completed, sponsored by Allergan.

COMPLETED
Registry status
NA
Development phase
213 participants
Enrollment target

Study Summary

The purpose of this study is to demonstrate the safety and effectiveness of Juvederm(R) Ultra XC Injectable Gel for lip augmentation

Interventions

  • DEVICE hyaluronic acid gel

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2010-08-01
Est. Completion 2015-06-15
Phase NA

Sponsor

Allergan

314 total trials

What the Registry Record Tells You About NCT01197495

The ClinicalTrials.gov registry entry for NCT01197495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which hyaluronic acid gel is the first listed.

NCT01197495 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01197495 about?

NCT01197495 is a clinical study titled "Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation". The purpose of this study is to demonstrate the safety and effectiveness of Juvederm(R) Ultra XC Injectable Gel for lip augmentation

What is the current status of trial NCT01197495?

This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2010-08-01. Estimated completion is 2015-06-15.

What interventions are being tested in trial NCT01197495?

The interventions under investigation include: hyaluronic acid gel (DEVICE).

Who is sponsoring clinical trial NCT01197495?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.